Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07461506
NA

NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks

Sponsor: nCap Medical

View on ClinicalTrials.gov

Summary

This is a randomized (1:1), placebo-controlled clinical trial that will examine the feasibility and effectiveness of a 2-day application of the NeuroCuple device for pain relief and reduction of opioid use following wisdom teeth extraction. The primary objectives are to determine whether the active NeuroCuple reduces postoperative pain and decreases opioid consumption compared to a sham (placebo) device. A total of 120 participants will be enrolled over a 1-year period and randomized to receive either the active device or an identical-appearing placebo device without the captor array layer.

Official title: Mitigating Opioid Use Disorder Risk With Enhanced Opioid Sparing Pain Relief for Wisdom Teeth Extractions With a Novel Nanotechnology

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2026-06-30

Completion Date

2027-09-30

Last Updated

2026-03-31

Healthy Volunteers

No

Interventions

DEVICE

NEUROCUPLE™ Patch

nCAP Medical has developed an effective, safe, opioid-sparing, non-pharmacological analgesic device, NeuroCuple®, that can reduce opioid use and surgical pain.

DEVICE

Sham Patch

The sham patch is identical to the active patch but with no active agents.

Locations (1)

University of Pittsburgh School of Dental Medicine

Pittsburgh, Pennsylvania, United States